Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide Read more
Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating Praluent Read more
Sanofi and Regeneron Present Positive Study Results for Investigational PD-1 Antibody REGN2810 Read more
BioCryst Reports Additional Positive Results From the Second Interim Analysis of Its APeX-1 Trial Read more